Target Name: LAMB3
NCBI ID: G3914
Other Name(s): BM600-125KDA | Kalinin B1 chain | LAM5 | OTTHUMP00000034640 | Nicein-125kDa | LAMB3 variant 2 | JEB1B | LAMB3 variant 1 | LAMNB1 | Epiligrin subunit bata | LAMB3_HUMAN | laminin subunit beta 3 | Laminin-5 subunit beta | Epiligrin subunit beta | Laminin B1k chain | laminin S B3 chain | JEB1A | laminin-5 subunit beta | FLJ99565 | kalinin subunit beta | laminin B1k chain | BM600-125kDa | AI1A | Kalinin subunit beta | Laminin S B3 chain | Laminin subunit beta-3 | kalinin B1 chain | epiligrin subunit bata | Laminin subunit beta 3, transcript variant 1 | Nicein subunit beta | B3A | laminin, beta 3 (nicein (125kD), kalinin (140kD), BM600 (125kD)) | nicein subunit beta | laminin beta 3 | Laminin subunit beta 3, transcript variant 2 | Laminin beta 3 | nicein-125kDa | Laminin, beta 3 (nicein (125kD), kalinin (140kD), BM600 (125kD)) | OTTHUMP00000034555 | Laminin subunit beta-3 precursor | kalinin-140kDa

LAMB3: A Potential Drug Target and Biomarker for Diseases

LAMB3 (Laminin-binding protein 3) is a protein that is expressed in various tissues throughout the body, including the liver, spleen, kidney, and heart. It is a member of the family of laminins, which are a type of extracellular matrix protein that plays a critical role in cell-cell adhesion and tissue organization.

Recent studies have identified LAMB3 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is due to its unique structure and function, as well as its expressed expression in a wide range of tissues.

One of the key features of LAMB3 is its ability to interact with laminins. Laminins are composed of two main subunits: alpha-2 and alpha-3, which are responsible for interacting with heparan sulfate, a type of carbohydrate found in the extracellular matrix. LAMB3 is able to interact with alpha-2 and alpha-3 laminins, allowing it to regulate the activity of these subunits and potentially play a role in the regulation of cellular processes.

This ability to interact with laminins has led to the hypothesis that LAMB3 could be a drug target for diseases that are characterized by the disruption of normal cellular laminin interactions. For example, LAMB3 has been shown to be overexpressed in various tissues and tissues, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that it may play a role in the development and progression of these diseases.

In addition to its potential as a drug target, LAMB3 has also been identified as a potential biomarker for several diseases. For example, LAMB3 has been shown to be elevated in the blood of individuals with neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that it may be a useful diagnostic tool for these conditions.

Furthermore, LAMB3 has also been shown to be elevated in the urine of individuals with cancer, which could make it a useful biomarker for cancer detection and monitoring.

In conclusion, LAMB3 is a protein that has the potential to be a drug target and biomarker for a wide range of diseases. Its unique structure and function, as well as its expressed expression in various tissues, make it an attractive target for research into the regulation of cellular processes and the development of diseases. Further studies are needed to fully understand the role of LAMB3 in these processes and its potential as a drug and biomarker.

Protein Name: Laminin Subunit Beta 3

Functions: Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components

More Common Targets

LAMB4 | LAMC1 | LAMC1-AS1 | LAMC2 | LAMC3 | Laminin-5 | Laminins | LAMP1 | LAMP2 | LAMP3 | LAMP5 | LAMP5-AS1 | LAMTOR1 | LAMTOR2 | LAMTOR3 | LAMTOR3P1 | LAMTOR4 | LAMTOR5 | LAMTOR5-AS1 | LanC-like proteins | LANCL1 | LANCL1-AS1 | LANCL2 | LANCL3 | LAP3 | LAP3P2 | LAPTM4A | LAPTM4B | LAPTM4BP2 | LAPTM5 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) | LARGE-AS1 | LARGE1 | LARGE2 | LARP1 | LARP1B | LARP4 | LARP4B | LARP4P | LARP6 | LARP7 | LARS1 | LARS2 | LAS1L | LASP1 | LAT | LAT2 | LATS1 | LATS2 | LAX1 | LAYN | LBH | LBHD1 | LBP | LBR | LBX1 | LBX1-AS1 | LBX2 | LBX2-AS1 | LCA5 | LCA5L | LCAL1 | LCAT | LCDR | LCE1A | LCE1B | LCE1C | LCE1D | LCE1E | LCE1F | LCE2A | LCE2B | LCE2C | LCE2D | LCE3A | LCE3B | LCE3C | LCE3D | LCE3E | LCE4A | LCE5A | LCE6A | LCIIAR | LCK | LCLAT1 | LCMT1 | LCMT2 | LCN1 | LCN10 | LCN12 | LCN15 | LCN1P1 | LCN1P2 | LCN2 | LCN6 | LCN8 | LCN9 | LCNL1 | LCOR | LCORL